Fabry disease is a lysosomal condition with systemic clinical expression, caused by the tissue deposit of globotriaosylceramide, due to a deficit in its degradation. As with most lysosomal diseases, the presence of a mutation in a gene does not explain the pathophysiological disorders shown by patients. We conducted a comprehensive review of the pathogenic mechanisms that occur in Fabry disease.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.rce.2017.06.007 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!